Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beyond the biopsy in laser surgery

John Strasswimmer

    Archives of Dermatology
    |November 17, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Barbed suture-assisted high-tension cutaneous closure: Brief report of 493 surgical defects.

    Journal of the American Academy of Dermatology·2026
    Same author

    HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026
    Same author

    HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026
    Same author

    Melanoma outcome disparities in minority populations and the need for inclusive clinical trials for the benefit of all.

    Journal of the American Academy of Dermatology·2026
    Same author

    Neoadjuvant cemiplimab to facilitate Mohs micrographic surgery tumor extirpation and reduce surgical morbidity.

    JAAD international·2025
    Same author

    Twelve-year continuous therapy with vismodegib for advanced basal cell carcinoma: Tolerability and partial reversibility of adverse events.

    JAAD case reports·2025